|AHFS/Drugs.com||International Drug Names|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||349.82 g·mol−1|
|3D model (JSmol)|
Azasetron is an antiemetic which acts as a 5-HT3 receptor antagonist, pKi = 9.27  It is used in the management of nausea and vomiting induced by cancer chemotherapy (such as cisplatin chemotherapy). Azasetron hydrochloride is given in a usual dose of 10 mg once daily by mouth or intravenously. It is approved for marketing in Japan, and marketed exclusively by Torii Pharmaceutical Co., Ltd. under the trade names "Serotone I.V. Injection 10 mg" and "Serotone Tablets 10 mg". Pharmacokinetics data from S. Tsukagoshi.
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|